# EDGAR Filing Document

**Accession Number:** 0001840563
**File Stem:** 0001213900-26-009754
**Filing Date:** 2026-1
**Character Count:** 5523
**Document Hash:** 1b825785f9a24a40b5e911c95859ddb7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-009754.hdr.sgml**: 20260129

**ACCESSION NUMBER**: 0001213900-26-009754

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20240306

**FILED AS OF DATE**: 20260129

**DATE AS OF CHANGE**: 20260129

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Kovalyov George
- **CENTRAL INDEX KEY:** 0002107529

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41875
- **FILM NUMBER:** 26580026

**MAIL ADDRESS:**
- **STREET 1:** 120 NEWPORT CENTER DRIVE
- **STREET 2:** STE. 250
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 92660
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PMGC Holdings Inc.
- **CENTRAL INDEX KEY:** 0001840563
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 851399981
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 675 WEST HASTINGS STREET
- **STREET 2:** SUITE 805
- **CITY:** VANCOUVER
- **PROVINCE COUNTRY:** A1
- **ZIP:** V6B1N2
- **BUSINESS PHONE:** 888-445-4886

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 675 WEST HASTINGS STREET
- **STREET 2:** SUITE 805
- **CITY:** VANCOUVER
- **PROVINCE COUNTRY:** A1
- **ZIP:** V6B1N2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Elevai Labs Inc.
- **DATE OF NAME CHANGE:** 20211207

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Reactive Medical Labs Inc.
- **DATE OF NAME CHANGE:** 20210114

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Kovalyov George<br><sub>(Last) (First) (Middle)</sub><br>675 WEST HASTINGS STREET,<br>SUITE 805<br><sub>(Street)</sub><br>VANCOUVER, A1 V6B1N2<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>PMGC Holdings Inc. [ ELAB ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2024-03-06 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 0 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Options to Purchase Common Stock | 2025-03-06 | 2035-03-06 | Common Stock | 5<sup>(1)</sup> | 19600<sup>(2)</sup> | D |  |

---

### Footnotes:

(1) Reflects amount of shares underlying the options issued to George Kovalyov on a post-reverse stock split basis (1-for-200 reverse stock split in November 2024, 1-for-7 reverse stock split in March 2025, 1-for-3.5 reverse stock split in September 2025, and 1-for-4 reverse stock split in January 2026; such reverse stock splits, collectively, "Splits"). The options were issued to Mr. Kovalyov pursuant to that certain Director Offer Letter between PMGC Holdings Inc. and George Kovalyov on March 6, 2024 ("Offer Letter"), included as Exhibit 10.1 to PMGC Holdings Inc.'s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on March 7, 2024.

(2) Reflects exercise price of each share of common stock, par value $0.0001 per share ("Common Stock") underlying the options issued to Mr. Kovalyov pursuant to the Offer Letter, on a post-reverse stock split basis following the Splits.

**Signature:** /s/ George Kovalyov  
**Date:** 2026-01-29

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**